• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

    11/27/23 8:10:25 AM ET
    $AGRI
    $APLM
    $ATXI
    $BGLC
    Metal Fabrications
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AGRI alert in real time by email

    Shares of UP Fintech Holding Limited (NASDAQ:TIGR) surged in pre-market trading after the company results for the third quarter.

    UP Fintech Holding posted adjusted EPADS of 10 cents up from 4 cents in the year-ago period. The company’s quarterly sales came in at $70.10 million versus, $55.41 million a year earlier.

    UP Fintech shares rose 7% to $5.20 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Mobiquity Technologies, Inc. (NASDAQ:MOBQ) shares rose 27.3% to $0.5728 in pre-market trading after gaining around 7% on Friday.
    • Apollomics, Inc. (NASDAQ:APLM) shares rose 26.8% to $1.26 in pre-market trading after surging 14% on Friday. The company’s partner in China, Avistone Biotechnology Co. Ltd., recently received conditional approval from the National Medical Products Administration (NMPA) of China for the commercialization of vebreltinib to treat patients with MET exon 14 skipping non-small cell lung cancer (NSCLC).
    • Crown ElectroKinetics Corp. (NASDAQ:CRKN) rose 26.6% to $0.2243 in pre-market trading after gaining 4% on Friday.
    • FLJ Group Limited (NASDAQ:FLJ) shares surged 25.6% to $0.1941 in pre-market trading. FLJ Group shares jumped 45% on Friday after the company announced it entered into a definitive agreement to acquire Alpha Mind Technology.
    • Avenue Therapeutics, Inc.(NASDAQ:ATXI) gained 19.2% to $0.2240 in pre-market trading. Avenue Therapeutics recently posted a profit for the third quarter.
    • Cyngn Inc. (NASDAQ:CYN) gained 13.1% to $0.2712 in pre-market trading after gaining 4% on Friday.
    • CN Energy Group. Inc. (NASDAQ:CNEY) shares rose 12.5% to $0.1170 in pre-market trading after gaining more than 6% on Friday.
    • Bio-Path Holdings, Inc. (NASDAQ:BPTH) shares climbed 11.1% to $0.5364 in pre-market trading. Bio-Path Holdings recently posted a narrower-than-expected quarterly loss.
    • Captivision Inc. (NASDAQ:CAPT) rose 10.6% to $2.59 in pre-market trading after surging 44% on Friday.

    Losers

    • Impel Pharmaceuticals Inc. (NASDAQ:IMPL) dipped 22.7% to $0.6532 in pre-market trading after gaining 8% on Friday. Impel Pharmaceuticals recently announced exploration of strategic alternatives.
    • AgriFORCE Growing Systems Ltd. (NASDAQ:AGRI) shares fell 17.5% to $0.80 in pre-market trading.
    • Movella Holdings Inc. (NASDAQ:MVLA) fell 12.5% to $0.35 in pre-market.
    • Cuentas Inc. (NASDAQ:CUEN) shares fell 11.5% to $1.08 in pre-market trading after declining around 12% on Friday.
    • Trevena, Inc. (NASDAQ:TRVN) shares fell 10.1% to $0.5217 in pre-market trading. Trevena recently posted a third-quarter loss of 57 cents per share.
    • BioNexus Gene Lab Corp. (NASDAQ:BGLC) fell 10.1% to $0.8089 in pre-market trading after jumping 144% on Friday.
    • Hitek Global Inc. (NASDAQ:HKIT) fell 9.4% to $1.25 in pre-market trading after jumping over 8% on Friday.
    • Intelligent Bio Solutions Inc. (NASDAQ:INBS) shares fell 8.6% to $0.2650 in pre-market trading. The company recently reported first-quarter financial results.
    • Clearmind Medicine Inc. (NASDAQ:CMND) shares fell 7.5% to $0.1106 in pre-market trading. Clearmind Medicine recently announced a 1-for-30 reverse share split.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) fell 5.8% to $1.29 in pre-market trading after the company said Michael Kurlander, Chief Financial Officer, has stepped down from his role to pursue an outside opportunity. The company named Deputy Chief Financial Officer Evangelos Perros as Interim Chief Financial Officer.

     

    Now Read This: Top 5 Tech And Telecom Stocks That Could Blast Off In Q4

    Get the next $AGRI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGRI
    $APLM
    $ATXI
    $BGLC

    CompanyDatePrice TargetRatingAnalyst
    UP Fintech Holding Ltd
    $TIGR
    10/23/2025$13.10Buy
    UBS
    UP Fintech Holding Ltd
    $TIGR
    9/29/2025$12.00Buy
    Jefferies
    UP Fintech Holding Ltd
    $TIGR
    7/22/2025$14.00Neutral → Buy
    Citigroup
    Pagaya Technologies Ltd.
    $PGY
    6/12/2025$22.00Overweight
    Stephens
    UP Fintech Holding Ltd
    $TIGR
    3/19/2025Sell → Neutral
    Citigroup
    UP Fintech Holding Ltd
    $TIGR
    3/17/2025Buy
    BofA Securities
    Pagaya Technologies Ltd.
    $PGY
    2/7/2025$13.00 → $14.50Neutral → Buy
    Citigroup
    UP Fintech Holding Ltd
    $TIGR
    1/2/2025$9.40Buy
    Deutsche Bank
    More analyst ratings

    $AGRI
    $APLM
    $ATXI
    $BGLC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS initiated coverage on UP Fintech with a new price target

    UBS initiated coverage of UP Fintech with a rating of Buy and set a new price target of $13.10

    10/23/25 7:09:44 AM ET
    $TIGR
    Investment Bankers/Brokers/Service
    Finance

    Jefferies initiated coverage on UP Fintech with a new price target

    Jefferies initiated coverage of UP Fintech with a rating of Buy and set a new price target of $12.00

    9/29/25 9:59:26 AM ET
    $TIGR
    Investment Bankers/Brokers/Service
    Finance

    UP Fintech upgraded by Citigroup with a new price target

    Citigroup upgraded UP Fintech from Neutral to Buy and set a new price target of $14.00

    7/22/25 7:47:49 AM ET
    $TIGR
    Investment Bankers/Brokers/Service
    Finance

    $AGRI
    $APLM
    $ATXI
    $BGLC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Boyages Steven Constantine

    4 - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Issuer)

    3/20/26 5:00:35 PM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Hurd Jonathan Scott

    4 - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Issuer)

    3/20/26 5:00:31 PM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Sakiris Spiro Kevin

    4 - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Issuer)

    3/20/26 5:00:32 PM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    $AGRI
    $APLM
    $ATXI
    $BGLC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    /C O R R E C T I O N -- Cyngn/

    In the news release, At GTC, Cyngn Advances High-Fidelity Forklift Simulation Through FMU Integration in NVIDIA Isaac Sim, issued 16-Mar-2026 by Cyngn over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end: At GTC, Cyngn Advances High-Fidelity Forklift Simulation Through FMU Integration in NVIDIA Isaac Sim MOUNTAIN VIEW, Calif., March 16, 2026 /PRNewswire/ -- Cyngn (NASDAQ:CYN) announced it is integrating its high-fidelity forklift vehicle models into NVIDIA Isaac Sim, an open simulation framework for developing autonomous systems.

    3/16/26 7:10:00 AM ET
    $CYN
    EDP Services
    Technology

    Clearmind Medicine Reports Successful Ongoing Treatment of Participants at US Sites in its FDA-approved CMND-100 Phase I/IIa Clinical Trial for Alcohol Use Disorder

    Vancouver, Canada, March 19, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ:CMND) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced the successful continuation of treatment of participants in the third cohort of its ongoing FDA-approved Phase I/IIa clinical trial evaluating CMND-100, the Company's proprietary non-hallucinogenic MEAI-based oral drug candidate, for the treatment of Alcohol Use Disorder (AUD). This positive progress follows the Company's recent announcement on March

    3/19/26 8:45:00 AM ET
    $CMND
    Biotechnology: Pharmaceutical Preparations
    Health Care

    UP Fintech Holding Limited Reports Unaudited Fourth Quarter And Full Year 2025 Financial Results

    SINGAPORE, March 19, 2026 (GLOBE NEWSWIRE) -- UP Fintech Holding Limited (NASDAQ:TIGR) ("UP Fintech" or the "Company"), a leading online brokerage firm focusing on global investors, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025. Mr. Wu Tianhua, Chairman and CEO of UP Fintech stated: "Both of our financial and operating performance have achieved significant growth in the full year of 2025. The full year total revenue amounted to US$612.1 million, a 56.3% increase from 2024. Total revenue in the fourth quarter reached US$175.6 million, representing a year-over-year increase of 41.5% and remaining flat compared to the prior quart

    3/19/26 4:00:00 AM ET
    $TIGR
    Investment Bankers/Brokers/Service
    Finance

    $AGRI
    $APLM
    $ATXI
    $BGLC
    SEC Filings

    View All

    Intelligent Bio Solutions Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

    8-K - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Filer)

    3/23/26 4:30:22 PM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    SEC Form 424B5 filed by Intelligent Bio Solutions Inc.

    424B5 - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Filer)

    3/23/26 4:10:14 PM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    Bio-Path Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

    8-K - BIO-PATH HOLDINGS, INC. (0001133818) (Filer)

    3/19/26 9:30:07 PM ET
    $BPTH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGRI
    $APLM
    $ATXI
    $BGLC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for TRUDHESA issued to IMPEL NEUROPHARMA INC

    Submission status for IMPEL NEUROPHARMA INC's drug TRUDHESA (ORIG-1) with active ingredient DIHYDROERGOTAMINE MESYLATE has changed to 'Approval' on 09/02/2021. Application Category: NDA, Application Number: 213436, Application Classification: Type 5 - New Formulation or New Manufacturer

    9/13/21 2:21:35 PM ET
    $IMPL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for DIHYDROERGOTAMINE MESYLATE issued to IMPEL NEUROPHARMA INC

    Submission status for IMPEL NEUROPHARMA INC's drug DIHYDROERGOTAMINE MESYLATE (ORIG-1) with active ingredient DIHYDROERGOTAMINE MESYLATE has changed to 'Approval' on 09/02/2021. Application Category: NDA, Application Number: 213436, Application Classification: Type 5 - New Formulation or New Manufacturer

    9/7/21 1:04:43 PM ET
    $IMPL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGRI
    $APLM
    $ATXI
    $BGLC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Welch David Ryan was granted 97,410 shares and bought $1,424 worth of shares (11 units at $129.42), increasing direct ownership by 647% to 97,421 units (SEC Form 4)

    4 - AGRIFORCE GROWING SYSTEMS LTD. (0001826397) (Issuer)

    9/30/25 7:56:59 PM ET
    $AGRI
    Metal Fabrications
    Industrials

    Chief Business Officer Yulzari Yahav bought $248,171 worth of Class A Ordinary Share (23,600 units at $10.52), increasing direct ownership by 8% to 311,637 units (SEC Form 4)

    4 - Pagaya Technologies Ltd. (0001883085) (Issuer)

    10/9/24 5:42:46 PM ET
    $PGY
    Finance: Consumer Services
    Finance

    Director Kranzler Jay D bought $1,250 worth of shares (500 units at $2.50), increasing direct ownership by 417% to 620 units (SEC Form 4)

    4 - AVENUE THERAPEUTICS, INC. (0001644963) (Issuer)

    10/1/24 4:15:13 PM ET
    $ATXI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGRI
    $APLM
    $ATXI
    $BGLC
    Leadership Updates

    Live Leadership Updates

    View All

    Cyngn Adds Former Lyft Exec, Ran Makavy, to Board

    Mr. Makavy led growth at Lyft and later ran its core platform through the 2019 IPO. He also founded Snaptu, which was acquired by Facebook in 2011.MOUNTAIN VIEW, Calif., Feb. 25, 2026 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced the appointment of Ran Makavy to its Board of Directors. He brings senior growth and platform leadership experience from Lyft and Facebook, where he helped scale large technology businesses through high-growth phases. At Lyft, Makavy built the growth team which was responsible for getting more drivers and riders to use Lyft and getting them to use

    2/25/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman

    Enhanced board oversight aligns subsidiary with disciplined capital allocation and strategic evaluation framework KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BioNexus" or the "Company"), today announced the completion of a governance restructuring of its wholly owned subsidiary, Chemrex Corporation Sdn. Bhd. ("Chemrex"). As part of this restructuring, Chemrex's board has been streamlined to two directors: Matthew L. Barsing, ChairmanAngeline Chong, Chief Financial Officer of BioNexus, Director New officers are expected to be appointed in the coming months. Chemrex remains a wholly owned private subsidiary of BioNexus and operates un

    2/23/26 8:30:00 AM ET
    $BGLC
    Medical Specialities
    Health Care

    Cyngn Partners with Chandler Automation, Expands into Agriculture

    MOUNTAIN VIEW, Calif., Dec. 23, 2025 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced that Chandler Automation has joined its dealer network and will begin offering Cyngn's autonomous DriveMod Tugger to food processors and packers in the agriculture sector. Chandler Automation is a full-service partner in factory automation, specializing in optical sorting, inspection, robotic palletizing, and custom processing machinery. Known for delivering tailored, high-performance systems, Chandler empowers food processors to reduce labor costs, boost efficiency, and stay competitive wi

    12/23/25 7:00:00 AM ET
    $CYN
    EDP Services
    Technology

    $AGRI
    $APLM
    $ATXI
    $BGLC
    Financials

    Live finance-specific insights

    View All

    UP Fintech Holding Limited Reports Unaudited Fourth Quarter And Full Year 2025 Financial Results

    SINGAPORE, March 19, 2026 (GLOBE NEWSWIRE) -- UP Fintech Holding Limited (NASDAQ:TIGR) ("UP Fintech" or the "Company"), a leading online brokerage firm focusing on global investors, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025. Mr. Wu Tianhua, Chairman and CEO of UP Fintech stated: "Both of our financial and operating performance have achieved significant growth in the full year of 2025. The full year total revenue amounted to US$612.1 million, a 56.3% increase from 2024. Total revenue in the fourth quarter reached US$175.6 million, representing a year-over-year increase of 41.5% and remaining flat compared to the prior quart

    3/19/26 4:00:00 AM ET
    $TIGR
    Investment Bankers/Brokers/Service
    Finance

    UP Fintech Holding Limited to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

    SINGAPORE, March 06, 2026 (GLOBE NEWSWIRE) -- UP Fintech Holding Limited ("UP Fintech" or the "Company") (NASDAQ:TIGR), a leading online brokerage firm focusing on global investors, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2025, before the U.S. market opens on March 19, 2026. UP Fintech's management will hold an earnings conference call at 8:00 AM on March 19, 2026, U.S. Eastern Time (8:00 PM on March 19, 2026, Singapore/Hong Kong Time). Conference Call Information: All participants wishing to attend the call must preregister online before they may receive the dial-in numbers. Preregistration may require a few min

    3/6/26 3:00:00 AM ET
    $TIGR
    Investment Bankers/Brokers/Service
    Finance

    Cyngn Announces Date for 2025 Fourth Quarter and Year-End Financial Results

    MOUNTAIN VIEW, Calif., March 5, 2026 /PRNewswire/ -- Cyngn (NASDAQ:CYN) will announce its 2025 fourth quarter and year-end financial results for the period ended December 31, 2025, on Wednesday, March 25, 2026, after the close of market. The financial results will be available on the Cyngn website under "News & Events" at https://investors.cyngn.com/.  The Company will not host an earnings call.About CyngnCyngn develops and deploys autonomous vehicle technology for industrial organizations like manufacturers and logistics companies. The Company addresses significant challenges f

    3/5/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    $AGRI
    $APLM
    $ATXI
    $BGLC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Mobiquity Technologies Inc.

    SC 13G/A - Mobiquity Technologies, Inc. (0001084267) (Subject)

    11/20/24 7:44:24 PM ET
    $MOBQ
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Avenue Therapeutics Inc.

    SC 13D/A - AVENUE THERAPEUTICS, INC. (0001644963) (Subject)

    11/15/24 4:05:50 PM ET
    $ATXI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Mobiquity Technologies Inc.

    SC 13G/A - Mobiquity Technologies, Inc. (0001084267) (Subject)

    11/14/24 7:18:49 PM ET
    $MOBQ
    Advertising
    Consumer Discretionary